ADVERTISEMENT

Original Article

Basic Fibroblast Growth Factor Treatment for Skin Ulcerations in Scleroderma
Yamanaka K-i, Inaba T, Nomura E, Hurwitz D, Jones DA, Hakamada A, Isoda K, Kupper TS, Mizutani H
Cutis. 2005;76:373-376.
We report the use of topical application of recombinant human basic fibroblast growth factor (rhbFGF) to successfully treat therapy-resistant, chronic leg ulcers in scleroderma. Endothelial cell FGF receptors are directly stimulated by bFGF; also, bFGF promotes the regeneration of capillary-rich granulation tissue. We conclude that topical bFGF may be a powerful new pharmacologic tool for treating severe skin ulcers.

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
Quick Poll
Do you think the tanning tax will have an impact on decreasing indoor tanning rates?


ADVERTISEMENT

Breaking News

More News